Consistently, mutations in the TP53 gene (i.e., loss of normal functions of p53) were found to statistically correlate with the generation of cancer stem cell-like cell transcriptional patterns in breast cancers and lung cancers [12]. Here, TP53 is linked to breast carcinoma.